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Activation of the Pax2 gene marks the intermediate mesoderm shortly after gastrulation, as the
mesoderm becomes compartmentalized into paraxial, intermediate, and lateral plate. Using an EGFP
knock-in allele of Pax2 to identify and sort cells of the intermediate mesodermal lineage, we compared
gene expression patterns in EGFP positive cells that were heterozygous or homozygous null for Pax2.
Thus, we identiﬁed critical regulators of intermediate mesoderm and kidney development whose
expression depended on Pax2 function. In cell culture models, Pax2 is thought to recruit epigenetic
modifying complex to imprint activating histone methylation marks through interactions with the
adaptor protein PTIP. In kidney organ culture, conditional PTIP deletion showed that many Pax2 target
genes, which were activated early in renal progenitor cells, remained on once activated, whereas Pax2
target genes expressed later in kidney development were unable to be fully activated without PTIP. In
Pax2 mutants, we also identiﬁed a set of genes whose expression was up-regulated in EGFP positive cells
and whose expression was consistent with a cell fate transformation to paraxial mesoderm and its
derivatives. These data provide evidence that Pax2 speciﬁes the intermediate mesoderm and renal
epithelial cells through epigenetic mechanisms and in part by repressing paraxial mesodermal fate.
& 2015 Elsevier Inc. All rights reserved.
Introduction
The vertebrate Pax gene family was identiﬁed based on
sequence homology to a subset of Drosophila segmentation genes
that encode a conserved DNA binding domain called the paired-
box. In mammals, Pax genes control the speciﬁcation of particular
cells and tissues, such as the eye, the vertebral column, the
thymus, and parts of the nervous system, and have also been
linked to cancer and human congenital malformations (Chi and
Epstein, 2002; Robson et al., 2006). The Pax2 gene is crucial for the
development of the kidney and the reproductive tract, both of
which are derived from the intermediate mesoderm (Dressler,
2006, 2009). Pax2 is among the earliest markers for the inter-
mediate mesoderm, along with the related gene Pax8 (Bouchard
et al., 2002) and the homeodomain protein Lhx1 (Tsang et al.,
2000). This Pax2 positive intermediate mesoderm generates the
nephric, or Wolfﬁan, duct, an outgrowth of the duct called the
ureteric bud (UB), and the surrounding metanephric mesenchyme
(MM). Kidney development starts when the UB invades the MM
and transmits inductive signals, such as Wnt9b (Carroll et al.,
2005), to promote condensation of the MM around the UB tips.
These UB tip associated Cap mesenchyme cells (CM) continue to
express Pax2 and are the stem cells of the nephron that generate
all of the epithelial derivatives, including distal, proximal and
glomerular epithelium (Kobayashi et al., 2008; Mugford et al.,
2008). The CM undergoes a mesenchymal-to-epithelial transition
to generate all the epithelial cells of the developing nephron.
However, Pax2 expression is down-regulated in the podocyte
precursor cells and in the mature epithelial cells of the nephron
as development comes to an end (Ryan et al., 1995).
Loss of Pax2 function results in complete renal and reproduc-
tive tract agenesis in mice (Torres et al., 1995; Sooﬁ et al., 2012). In
humans, multiple Pax2 mutations have been identiﬁed in patients
with renal coloboma syndrome, characterized by dysplasia, hypo-
plasia, and vesicoureteral reﬂux (Sanyanusin et al., 1995; Bower
et al., 2012). The reactivation of Pax2 expression is also observed in
adult kidneys after acute injury, suggesting a critical role for Pax2
in regenerating the epithelia (Imgrund et al., 1999; Humphreys
et al., 2008; Kusaba et al., 2014). Ectopic or deregulated expression
of Pax2 is also seen in Wilms' tumor (Dressler and Douglass, 1992),
renal cell carcinoma (Gnarra and Dressler, 1995), and polycystic
kidney disease (Ostrom et al., 2000), where it is thought to
promote proliferation and/or survival. Despite its central role in
kidney development and renal disease, the biochemistry of Pax2
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and its affects on gene regulation are not well characterized in a
developing tissue. Several target genes have been identiﬁed,
including Gata3 (Grote et al., 2006) and Gdnf (Brophy et al.,
2001), but these are likely to represent only a fraction of the total
genes that may be regulated by Pax2. A more recent report showed
that in the pro/mesonephros a core transcriptional network
formed by Pax2, Gata3 and Lhx1 regulates the expression of
downstream effectors of kidney development (Boualia et al.,
2013a).
In cell culture systems, Pax2 is known to recruit epigenetic
complexes to DNA that can positively or negatively regulate gene
expression. The adaptor protein PTIP, links Pax2 to an Mll3/4
histone H3K4 methyltransferase complex that imprints activating
epigenetic marks on chromatin (Patel et al., 2007). Similarly, PTIP
was shown to be required for H3K4me of immunoglobulin switch
regions that depend on long-range chromatin interactions
between Pax5, the 30 immunoglobulin heavy chain enhancer, and
the new transcription start sites (Daniel et al., 2010; Schwab et al.,
2011). Yet, Pax2 can also recruit Polycomb repressor complexes to
chromatin, depending upon the availability of the co-repressor
Groucho/Grg4/Tle4 (Patel et al., 2013). In the presence of Grg4,
Pax2 is dephosphorylated (Cai et al., 2003), PTIP and the MLL
complex are displaced, and the arginine methyltransferase PRMT5
and the H3K27 methyltransferase Ezh2 are recruited to silence
gene expression (Patel et al., 2012). Still, it is not clear whether
Pax2 is primarily an activator or a repressor within the developing
intermediate mesoderm and kidney.
In this report, we identify the genes regulated by Pax2 in renal
progenitor cells using novel Pax2EGFP alleles that allow for the
sorting of cells from embryonic intermediate mesoderm and its
early derivatives. Microarray analyses determined the complete
expression proﬁles of Pax2 null and Pax2 positive renal progenitor
cells. The data conﬁrm that many critical kidney developmental
genes require Pax2 for expression. Furthermore, the data suggest
that in the absence of Pax2, some genes normally expressed in the
paraxial mesoderm and in interstitial stromal cells are now
expressed within the intermediate mesodermal cells. Moreover,
to address the role of PTIP during kidney development, we
developed an organ culture system in which the gene encoding
PTIP (Paxip1) could be deleted from all cells of the developing
kidney at a speciﬁc stage of development. The data indicate that
Pax2 regulated genes can be PTIP dependent or PTIP independent
and conﬁrm a central role for Pax2 in regulating critical develop-
mental genes and pathways in the kidney.
Materials and methods
Animals
Mice were kept according to NIH guidelines. All procedures were
approved by the University Committee on Use and Care of Animals at
the University of Michigan. The Egfp/þ mice were generated as
previously described (Sooﬁ et al., 2012). R26CP mice were obtained
by crossing the Ptipf/f mouse strain (Kim et al., 2007) with B6.129-Gt
(ROSA)26Sortm1(cre/ERT2)Tyj/J mice (Jackson Labs, Stock no. 8463). The
progeny was then crossed with Ptipf/f mice to generate R26CP
mice carrying two copies of the Ptipf/f locus. R26CP mice were then
bred to the reporter R26TdTomato strain (Jackson Labs, Stock No. 7576)
to generate R26CPTG mice. For genotyping, genomic DNA was pre-
pared by a standard method and ampliﬁed by PCR using the following
primer pair sets: Egfp – CCCACCGTCCCTTCCTTTTCTCCTCA, GAAAGGC-
CAGTGTGGCCTCTAGGGTG; Pax2 - CCCACCGTCCCTTCCTTTTCTCCTCA,
GAAAGGCCAGTGTGGCCTCTAGGGTG, AGACTGCCTTGGGAAAAGCGC;
Ptip – GGTTCTCTTGCAGCATCTCC, GGGAACTGATCTTCGATGAGG; Cre
– CGAGTGATGAGGTTCGCAAG, TGATGTAACGAACCTGGTCG; TdTomato
– CTCTGCTGCCTCCTGGCTTCT, CGAGGCGGATCACAAGCAATA, TCAAT
GGGC GGGGGTCGTT.
Primers were sequenced at the University of Michigan DNA
Sequencing Core Facility.
Fluorescent activated cell sorting
The entire intermediate mesoderm regions, comprising the
mesonephric tubules, nephric duct and metanephric mesenchyme,
dissected from embryonic day (E) 11.5 Egfp/þ and Egfp/Egfp
embryos, was dissociated using 0.25% trypsin-EDTA for 5 min.
Cells were resuspended in 1% FBS in PBS and ﬁltered through a
70 μm cell strainer (BD Falcon) to remove cell clumps. Cells
expressing EGFP were isolated using a FACSAria III (BD) cell sorter.
Microarray expression analysis
Total RNA was extracted from EGFP positive FACS-sorted cells
using TRIzol reagent (Life Technologies) and RNeasy Mini Kit (Qiagen).
Microarray expression analysis was performed using three inde-
pendent cohorts of embryos and carried out by the University of
Michigan Comprehensive Cancer Center Affymetrix and Microarray
Core Facility using a Mouse 430 2.0 Affymetrix GeneChip 3 expression
arrays (Affymetrix), as described (Zhang et al., 2012). Expression
values for each gene was calculated using the robust multi-array
average (RMA) method and ﬁtted to weighted linear models in R
using the Affymetrix package of bioconductor (Irizarry et al., 2003;
Zhang et al., 2012). The complete dataset and original Cel ﬁles can be
accessed at GEO repository (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE64129).
Bioinformatics analysis
Gene ontology and functional expression analyses of the genes
whose expression was altered in Pax2 null embryos, compared to
controls was carried out using Genomatix Genome Analyzer
(Genomatix Software GmbH) and ToppGene Suite (Chen et al.,
2009). Analysis parameters were kept as default.
RNA reverse transcription and real-time PCR
Real time PCR analysis of EGFP positive FACS-sorted cells was
carried out using the same RNA used for microarray expression
analysis. In details, 100 ng of total RNA was reverse transcribed
into cDNA using SuperScript II Reverse Transcriptase (Life Tech-
nologies). cDNA templates were ampliﬁed with iTaq Universal
SYBR Green Supermix (Bio-Rad) in a StepOne Plus real-Time PCR
System (Life Technologies). Real time PCR analysis of organ
cultures was performed using 100 ng of total RNA extracted
from 5 days ex vivo cultured R26PTG and R26CPTG kidney rudi-
ments as described above. The following primer pairs were used:
Bmp7 – CAGCCAGAATCGCTCCAAGA, GCAATGATCCAGTCCTGCCA;
Cited1 – CTCTGGGAAGGAGGATGCC, CCAGAGGAGCTAGTGGGAAC;
Eya1 – ATCTAACCAGCCCGCATAGC, CTGCTTCCGAGAGCTGAACC;
Gdnf – CCAGTGACTCCAATATGCCTGA, TGCCGATTCCTCTCTCTTCG;
Hnf4a – TACTCCTGCAGGTTTAGCCG, CAGCCCGGAAGCACTTCTTA;
Hprt – GTTGGGCTTACCTCACTGCT, TCATCGCTAATCACGACGCT;
Msx1 – GCCCCGAGAAACTAGATCGG, GGACTCAGCCGTCTGGC; Osr1 –
TTCGTTTGCAAGTTCTGTGG, Pax9 - GACCAAGGAGTGAGCGACA,
CACCCATGTCCAGCCACATA; TGTAGCGTCTTGTGGACAGC; Six2 –
GCAAGTCAGCAACTGGTTCA, AACTGCCTAGCACCGACTTG; Ret –
AGAGCAGAGACTACTTGGACCT, AGTAAATGCATGTGAAATTCTACCA;
Twist2 –GTCTCAGCTACGCCTTCTCC, CAGGTGGGTCCTGGCTTG; Wnt4
–GCAGGAAGGCCATCTTGACA, CACGTCTTTACCTCGCAGGA.
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In situ hybridization
Whole mount RNA in situ hybridization was performed on
E11.5 Egfp/þ and Egfp/Egfp embryos, as described (Sooﬁ et al.,
2012). In situ hybridization was also performed on 5 days ex vivo
cultured R26CP and control embryonic kidney rudiments. In
details, the samples were ﬁxed in 4% PFA in PBS for 1 h at 4 1C,
then washed three times in PBSþ0.1% Tween-20 (PBT) for 10 min
at room temperature and de-hydrated through a PBT/methanol
series. Templates for digoxigenin (DIG)-labeled riboprobes were
generated by PCR ampliﬁcation of E11.5-E15.5 mouse embryo
cDNAs and sequenced. Primer pairs used to prepare riboprobe
templates are listed in Table S6. Morphometric analysis of whole
mount RNA in situ hybridization performed on kidney rudiments
was carried out using ImageJ software.
Organ culture
E11.5 R26CPTG and control kidneys were cultured on 0.4 μm
Transwell ﬁlter inserts (Costar) in Dulbecco's Modiﬁed Eagle
Medium supplemented with 10% FCS and 1 penicillin/strepto-
mycin for 5 days. To induce Cre-mediated recombination, kidneys
were cultured in the presence of 500 nM 4-hydroxytamoxifen
(Sigma) for the initial 48 h of culture.
Western blot analysis
Single R26CPTG kidneys cultured for 5 days were carefully
detached from the membranes and lysed in 2X SDS buffer (20%
glycerol, 4% sodium dodecyl sulfate, 0.2 M dithiothreitol, 125 mM
Tris, pH 6.8), as described (Zhang et al., 2012). Total proteins were
separated on 10% SDS-PAGE gel, transferred to PVDF membranes
and immunoblotted with a rabbit anti-Pax2 antibody (Dressler and
Douglass, 1992) and a rabbit anti-PTIP antibody (Patel et al., 2007).
Results
Pax2 controls the expression of critical regulators in kidney
development
Recently, we described two new Pax2 alleles that mark the
Pax2 positive cells with EGFP in developing embryos (Sooﬁ et al.,
2012). Loss of Pax2 function resulted in abnormal nephric duct
development, characterized by epithelial cells with increased
motility and reduced tight and adherent junctions. In the Pax2
null mutants, the EGFP positive metanephric mesenchyme was
also unable to respond to inductive signals. To identify potential
targets of the transcription factor Pax2 in renal progenitor cells, we
compared the whole expression proﬁle of Pax2 positive and Pax2
null cells after ﬂuorescent activated cell sorting (FACS) frommouse
embryos carrying the Pax2Egfp alleles. Mice carrying one Egfp allele
(Pax2Egfp/þ) are viable and fertile and express EGFP in all Pax2
expressing cells. The presence of two Egfp alleles (Pax2Egfp/Egfp)
completely abrogates Pax2 expression, however EGFP is still
present in all cells of the embryos that would otherwise express
Pax2 (Fig. 1A). In E11.5 Pax2 null embryos (Fig. 1A), the nephric
duct is present albeit the epithelial integrity is compromised, as
reported previously (Sooﬁ et al., 2012). There are also many Pax2
positive cells adjacent to the mutant nephric duct that would
correspond to Pax2 positive mesenchyme (Fig. 1A). Thus, we could
insure that EGFP positive cells from similar time points repre-
sented cells of similar origin, the only difference being the
presence or absence of Pax2 protein.
At E11.5, EGFP positive cells from both genotypes were clearly
distinguishable from the EGFP negative fractions, and could be easily
separated using FACS analysis (Fig. 1A and B). There was no
signiﬁcant difference in the numbers of EGFP positive cells between
tissues from Pax2Egfp/þ and Pax2Egfp/Egfp embryos. After total RNA
isolation, gene expression proﬁle analysis by Affymetrix microarrays
(Fig. 1C) identiﬁed 496 unique genes whose expression was altered
by more than 2-fold in Pax2 null renal progenitors, compared to
controls. The entire dataset is available from the Gene Expression
Omnibus (GEO accession number GSE64129). Among them, 286
genes were upregulated and 210 downregulated in Pax2 null renal
progenitor cells (See Table S1 for all signiﬁcant Pax2 regulated
genes). Strikingly, among the downregulated genes we identiﬁed
many known regulators of kidney development, such as Six2, Gdnf,
Eya1 and Lhx1 (See Table 1 for a select list of genes).
To further annotate the genes and networks whose expression
levels signiﬁcantly decreased in renal progenitor cells in the
absence of Pax2, we utilized Genomatix and Toppgene informatics
software to correlate gene expression, tissue distribution, and gene
ontologies. Using Genomatix, the most signiﬁcant tissues and
terms for genes whose expression was decreased in Pax2 mutants
included: nephrons, kidney, nephric duct, and epithelium (Fig. 1D).
Additional tissues and terms for this gene set included compo-
nents of the developing nervous system, many parts of which also
express Pax2. These data suggest some common targets for Pax2 in
the kidney and nervous system, which could include genes such as
Gdnf, Gfra1, Hdc, Lhx1, Ret, Sim1, Trpv4, and Vsnl1 that are
expressed in both tissues. The entire Genomatix tissue expression
analysis dataset and the associated genes that are down regulated
in Pax2 mutants are listed in Table S2.
Using Toppgene gene ontology and tissue expression analyses,
genes down regulated in Pax2 mutants also were associated with
mesonephric and metanephric development and were expressed in
intermediate mesoderm derivatives like the nephric duct, ureteric
bud, and metanephric mesenchyme (Table 2, and Table S3)
Although the expression of most of the kidney markers was
signiﬁcantly reduced in Pax2 null renal progenitor cells, the levels of
Cited1 transcripts, which are expressed in a sub-compartment of the
cap mesenchyme before induction (Brown et al., 2011), increased in
the absence of Pax2 (Table S1). This seems to indicate that Pax2 is
required to transition the early renal progenitor cells into a slightly
more differentiated cell population, which maintain the expression
of Six2 but loses the expression of Cited1 (Brown et al., 2011).
Increased expression of interstitial stroma and paraxial mesodermal
genes in Pax2 mutants
In the Pax2 mutant IMs, we also detected more than 280 genes
whose expression levels increased in the EGFP positive cells in the
absence of Pax2. As above, two independent bioinformatics soft-
ware packages were used to analyze the ontologies and functions
of genes whose expression is increased in Pax2 null EGFP positive
cells from E11.5 IM. Genomatix analyses of this gene data set found
many genes associated with the paraxial mesoderm and its
derivatives, the ectoderm and neural tissues, or stromal cells
(Fig. 1D). Among the most common tissues associated with the
upregulated gene data set were: mesoderm, tooth, somites, bone,
connective tissue, and muscle. The complete gene ontology and
expression sets and their associated tissue are listed in Table S4.
Using Toppgene for candidate prioritization, we also found that
genes upregulated in Pax2 mutants were primarily associated with
stromal and interstitial cells of the gonads and kidney (Table 2).
Gene ontology terms included: regulation of development, organ
morphogenesis, cell adhesion, and skeletal system development.
Cellular component analyses pointed to the extracellular matrix as
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a signiﬁcant component upregulated in Pax2 mutants. By compar-
ing to known gene expression atlases, such as Gudmap and
Facebase, genes up-regulated in Pax2 mutants are associated with
the interstitial cells in the gonads, the kidney capsule and the cells
of the kidney interstitium, and the paraxial mesoderm (Table S5).
These associations are based on microarray expression data sets
from laser capture dissection of speciﬁc regions in embryonic
kidneys, reproductive tracts, or whole embryos.
Given that paraxial mesoderm and the somites eventually
generate the axial skeleton and muscles, the data suggest that
Pax2 can suppress genes normally expressed in axial mesoderm
and its derivatives.
Conﬁrmation of expression patterns
To validate our microarray results, we performed whole mount
in situ hybridization (WISH) and/or quantitative RT-PCR on E11.5
Pax2 null and control embryos (Fig. 2). We analyzed the expression
pattern of multiple genes important for kidney development
whose expression signiﬁcantly decreased in renal progenitor cells
in the absence of Pax2. For kidney regulators, such as Bmp7, Lhx1,
Six2, Gata3, Osr1, Pax8 and Sall1, we dissected the entire inter-
mediate mesoderm region, including the mesonephros and devel-
oping metanephros, from the embryos after whole mount staining
of intact embryos. Control Pax2Egfp/þ embryos displayed the
Fig. 1. Expression analyses of Pax2 mutant intermediate mesoderm. (A) Microdissected E11.5 IMs are shown from heterozygous Pax2Egfp/þ and homozygous Pax2Egfp/Egfp
embryos, prior to single cell isolation. The nephric duct (red arrow), the mesonephros (white arrowhead) and the presumptive metanephric regions (white arrow) are
marked. Note EGFP positive mesenchymal cells all along the nephric duct in Pax2Egfp/Egfp embryos. (B) Fluorescent activated cell sorting of populations from either Pax2Egfp/þ
or Pax2Egfp/Egfp embryos. Note the nubmer of EGFP positive cells is not signiﬁcaintly different. (C) Heat map of Affymetrix microarrray expression analyses comparing EGFP
positive cells from Pax2Egfp/þ to Pax2Egfp/Egfp isolated from E11.5 IMs. Red indicates increased expression in the mutants, whereas blue idicateds decreaed expression in
mutants compared to heterozygotes. (D) Genomatix tissue expression analyses from candidate genes that activated in Pax2Egfp/Egfp embryos are in red and genes decreased in
Pax2Egfp/Egfp are in blue. P values reﬂect the probability of ﬁnding the number of genes in each tissue at random.
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correct expression pattern for all probes tested. For example, Six2
mRNA was detected in the cap mesenchyme surrounding the tips
of the UB, the expression of Bmp7 was noticeable along the
nephric duct, in the UB and MM, and Lhx1 was expressed along
the nephric duct and the UB (Fig. 2A). Ureteric bud, nephric ducts
and some mesonephric tubules also expressed the transcription
factors Gata3 and Pax8, whereas Sall1 mRNA was present only in
the MM (Fig. 2B). The expression levels of all genes identiﬁed as
decreased in Pax2Egfp/Egfp mutants by microarray analyses also
showed dramatic reductions in expression as determined by
WISH. These results validate the microarray analysis and further
conﬁrm that Pax2 positively regulates the expression of genes
important for kidney development.
Our microarray analysis also revealed that the kidney markers
Pax8 and Osr1 were both downregulated in Pax2 null renal
progenitor cells, however the reduction of the expression level
was less than two-fold compared to the controls. Thus, we decided
to assess the mRNA expression pattern of these genes by WISH. As
expected, in control embryos the expression of Pax8 mRNA was
present in the nephric duct, UB and mesonephric tubules, but
reduced in the Pax2 mutants (Fig. 2B). Osr1 expression was
detectable in the MM but was also signiﬁcantly reduced in the
Pax2 mutants (Fig. 2A). Furthermore, real time RT-PCR conﬁrmed
that the expression levels of the kidney markers Eya1, Gdnf and Ret
were reduced by 73%, 64% and 97%, respectively, in Pax2 null renal
progenitor cells, compared to controls (Fig. 2C). We also tested a
select group of genes that were upregulated in the Pax2 mutants
(Fig. 2C). The paraxial genes Pax9 and Msx1 were increased 4 and
3 fold respectively, whereas the mesenchymal expressed gene
Twist2 was upregulated 6 fold in Pax2 mutants. In our experience,
the Affymetrix microarrays are robust and reproducible, but
routinely underestimate the degree of differences in expression
levels, as both WISH and qRT-PCR routinely demonstrate greater
differences in mRNA expression levels compared to microarrays.
PTIP dependent and PTIP independent expression of kidney
developmental genes
Pax2 interacts with the nuclear protein PTIP to recruit a histone
methyltransferase complex to a DNA binding site, resulting in
increased levels of H3K4me3 (Patel et al., 2007). The PTIP protein
is encoded by the Paxip1 gene and is required for early embryonic
development, as Paxip1–/– embryos are developmentally arrested
at E9.5 (Cho et al., 2003). Loss of PTIP results in spontaneous
differentiation of embryonic stem (ES) cells (Kim et al., 2009),
altered arrhythmias in adult murine cardiomyocytes (Stein et al.,
2011) and chronic glomerular disease in adult mice (Lefevre et al.,
2010). To investigate the role of PTIP during kidney development,
we made use of an ex vivo organ culture system to delete Paxip1 in
E11.5 R26CPTG (Creþ) kidneys by adding 4-hydroxytamoxifen
(4-OHT) to the culture medium at day 0 of culture. R26PTG
(Cre–) kidneys were cultured in the presence of 4-OHT and used
as control. Both Creþ and Cre– kidneys also carried one R26TdTo-
mato allele, which enabled us to monitor Cre-mediated recombina-
tion, as the ubiquitously expressed TdTomato protein is replaced
by EGFP upon recombination (Muzumdar et al., 2007). EGFP
expression was detectable in Creþ kidneys after 24 h of culture
in the presence of 4-OHT (data not shown). After 5 days of culture
EGFP was present in most of the cells of Creþ kidneys, whereas
Cre– kidneys didn't show EGFP expression (Fig. 3A). TdTomato was
still present in Creþ kidneys, albeit in much fewer cells compared
Table 1
Renal developmental control genes suppressed in Pax2 mutants.
Gene Expression Mutant phenotype Reference
BMP7 MM, ND, UB Dysplasia, arrested development Dudley et al. (1995)
Eya1 MM Agenesis, absence of UB outgrowth Xu et al. (1999)
Gata3 ND, UB Ectopic UB, kidney dysplasia Grote et al. (2006)
Gdnf MM Agenesis due to lack of UB growth Moore et al. (1996) and Sanchez et al. (1996)
Hnf4a SSB, PT Heliot et al. (2013)
Irx1 SSB Defects in Xenopus pronephros Alarcon et al. (2008)
Irx3 CS Defects in Xenopus pronephros Reggiani et al. (2007)
Lhx1 ND, UB, CS Agenesis due to ND defects Tsang et al. (2000)
Npnt UB Agenesis or hypoplasia Linton et al. (2007)
Ret ND, UB Agenesis due to lack of UB outgrowth Schuchardt et al. (1996)
Sall1 MM, RV Agenesis due to defect in UB Nishinakamura et al. (2001)
Six2 CM Depletion of progenitor cells, dysplasia Self et al. (2006)
Vsnl1 UB tips Ola et al. (2011)
MM, metanephric mesenchyme; ND, nephric duct; UB, ureteric bud; CM, cap mesenchyme; RV, renal vesicle; CS, comma shaped body; SSB, s-shaped body.
Table 2
TOPPGENE analyses of Pax2 target genes.
Upregulated genes in Pax2 mutants
Co-expression atlas Source p
Value
No. (input/
annotated)
E13.5 testis, interstitial Gudmap 8.2E-
78
105/778
E13.5 ovary, mesenchyme Gudmap 1.6E-
56
88/798
E11.5 female gonad, mesenchyme Gudmap 3.0E-
55
69/424
E11.5 male gonad, mesenchyme Gudmap 3.9E-
55
88/828
Adult kidney, renal capsule Gudmap 2.5E-
38
70/780
E15.5 kidney, pelvic mesenchyme Gudmap 3.3E-
36
47/305
E15.5 kidney, peripheral blastema Gudmap 4.0E-
34
67/819
E8.5 paraxial mesoderm Facebase 2.9E-
32
70/970
Gene ontology, biological processes
Mesenchymal development GO:0060484 2.4E-
14
22/179
Mesenchyme cell differentiation GO:0048762 1.1E-8 18/152
Epithelial to mesenchyme transition GO:0001837 4.4E-7 10/84
Downregulated genes in Pax2 mutants
E11.5 kidney, ureteric bud Gudmap 4.6E-75 92/813
E15.5 kidney, cortical col. duct Gudmap 1.0E-59 79/775
P4 kidney, cap mesench., renal vesicle Gudmap 1.9E-41 64/785
E15.5 kidney, S-shaped body Gudmap 2.4E-33 44/406
E15.5 kidney, prox. tubules Gudmap 1.2E-31 54/759
Gene ontology, biological processes
Renal development GO:0001656 3.9E-10 12/94
Ureteric bud development GO:0001657 2.5E-9 12/110
Nephron development GO:0072006 1.1E-7 11/100
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to Cre– kidneys. Western blot analysis conﬁrmed the absence of
PTIP in Creþ kidneys (Fig. 3B). After 5 days of culture there were
no substantial differences in branching morphogenesis and size
between Creþ and Cre– kidneys (Fig. 3 and data not shown).
Quantitative RT-PCR demonstrated that in PTIP null kidneys Bmp7
was slightly downregulated compared to control kidneys, whereas
the expression level of both Osr1 and Six2 was reduced by 35% and
39%, respectively (Fig. 3C).
To identify the Pax2 target genes that may be affected in the
absence of PTIP during kidney development, we performed WISH
on 5 days cultured Creþ and Cre– kidneys. We started to analyze
the expression pattern of the early markers of kidney development
Bmp7, Osr1 and Six2. In Cre negative kidneys WISH staining
recapitulated the correct expression pattern of these genes. In
the absence of PTIP both the expression level and pattern of these
genes did not seem to be altered qualitatively (Fig. 4A). The surface
area of staining and the intensity of staining were measured by
quantitative morphometry to generate a relative measure of
expression as determined by WISH (Fig. 4C). As observed, the
expression of Bmp7 did not change signiﬁcantly upon PTIP
deletion, whereas the expression levels of Osr1 and Six2 mRNA
were down slightly to 75% of wild-type (Fig. 4C). We then assessed
the expression of two late markers of kidney development, Hnf4a
and Wnt4. By WISH staining, the expression levels of both genes
was reduced in PTIP null kidneys compared to control explants,
however the spatial pattern of gene expression was not perturbed
(Fig. 4B and D). Quantitative RT-PCR showed that in the absence of
PTIP, Hnf4a and Wnt4 expression was reduced by 50% and 44%,
respectively (Fig. 3C). Quantitation of the WISH staining was
consistent with the qRT-PCR data and showed a reduction of
approximately 60% and 75% respectively. Surprisingly, both RT-PCR
and WISH showed that Cited1, whose expression is found in early
renal progenitors of the cap mesenchyme (Brown et al., 2011), was
signiﬁcantly downregulated in PTIP null kidneys compared to the
controls (Figs. 3C, 4B and D). Since the Cited1 cells are thought to
represent a sub-population of true renal progenitor cells, the data
suggest that PTIP is essential for maintaining at least part of the
transcriptome of renal stem cells.
Discussion
Gene regulatory networks are thought to establish and main-
tain the differentiated state. The Pax genes expression is activated
early in development, when tissues are ﬁrst speciﬁed with respect
to their eventual fates, and are critical for cell lineage decisions.
Prior studies implicate Pax2 in a core regulatory network, which
includes Gata3 and Lhx1, that deﬁnes the intermediate mesoderm
Fig. 2. Conﬁrmation of gene expresssion differences of kidney developmental regulators. Intermediate mesoderm was dissected free from surrounding tissues and includes
the posterior metanephros (arrow) the nephric duct (arrowhead). (A) Whole mount in situ hybridization of genes suppressed in Pax2Egfp/Egfp mutant IMs show decreased
Bmp7, Lhx1, and Six2 in the developing metanephros (arrow) at E11.5. (B) Whole mount in situ hybridization of Gata3 and Sall1 show decrease expression in Pax2Egfp/Egfp in
the metanephric mesenchyme (arrow) and in the nephric duct epithelia (arrowhead). White arrowheads indicate mesonephric tubules. (C) Quantitative RT-PCR for mRNAs of
Eya1, Gdnf, and c-Ret all show signiﬁcaintly decreased levels of transcripts in Pax2Egfp/Egfp IMs at E11.5. All qRT-PCRs were done in triplicate and normalized to Hprt expression
levels with error bars representing one standard deviation from the mean.
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and the renal epithelial cells derived from this mesoderm (Boualia
et al., 2013a). In this report, we deﬁne a complete data set of genes
affected by the loss of Pax2 in the intermediate mesoderm and its
early derivatives, the nephric duct, the mesonephros and the
metanephric mesenchyme. The genes include many known kidney
developmental regulators, such as Gdnf, c-Ret, Six2, Sall1, and
Lhx1, but also affected are genes and proteins associated with
glycosylation, cell membranes, cell-cell signaling, and cell
adhesion.
We utilized gene ontology and tissue expression software to
analyze and cluster the genes affected by the loss of Pax2 in the
intermediate mesoderm. Genomatix software utilizes available
literature to associate gene expression with particular tissues
and processes. Toppgene analyses are similar but also include
comparisons to gene expression atlases and tissue expression
databases. As expected, Pax2 mutants showed decreased expres-
sion of early kidney developmental genes, many of which had
been previously identiﬁed. More surprising was our ﬁnding that in
Pax2 mutants the intermediate mesodermal cells, as marked by
EGFP expression, had increased expression of interstitial stromal
genes and genes associated with paraxial mesoderm. For example,
Pax9 expression is observed in paraxial mesoderm and the
sclerotomes, which will contribute to the vertebral column
(Neubuser et al., 1995; Peters et al., 1999; Rodrigo et al., 2003).
Yet EGFP positive cells from the IM of Pax2 mutants show a four
fold upregulation of Pax9. This suggests a cellular fate transforma-
tion from renal epithelial progenitor cell to a stromal or mesench-
ymal phenotype and a fate more consistent with paraxial
mesoderm and its derivatives. Thus Pax2 may be specifying a
boundary between paraxial and intermediate mesoderm along the
medio-lateral body axis. Similarly, Pax6 and Pax2 function within
the central nervous system to deﬁne the boundaries between the
developing forebrain and midbrain (Matsunaga et al., 2000). Given
that Pax genes were originally identiﬁed based on homology to
Drosophila pair-rule segmentation genes, which deﬁne the para-
segments in the ﬂy embryo, the speciﬁcation of boundaries
between developing tissue compartments may be an evolutiona-
rily conserved feature of Pax genes.
Despite the genetic evidence for cell lineage speciﬁcation in
development, the biochemistry of Pax protein function remains
poorly characterized. The conserved 128 amino acid paired box
binds a bipartite DNA sequence that spans nearly two turns of the
DNA helix. (Czerny et al., 1993; Epstein J.A. et al., 1994; Czerny and
Busslinger, 1995; Xu et al., 1995; Phelps and Dressler, 1996) The
crystal structure shows three amino-terminal α-helices that
resemble a homeo-domain, followed by a carboxyl terminal region
with three smaller α-helices. The amino terminal α-helices contact
the 30 part of the bipartite target sequence, whereas the carboxyl
Fig. 3. Deletion of PTIP in embryonic kidney organ cultures. (A) Tamoxifen induction of the Rosa26-Cre-ER transgene activates EGFP expression and suppresses dT-Red in the
kidney mesenchyme. (B) Western blotting of protein lysates from individual kidney rudiments that carry the Rosa26-Cre-ER transgene (C/þ) and wild-type controls cultured
with tamoxifen. Note that the 120 kD PTIP protein is absent in kidney culures that are positive for Cre-ER. (C) qRT-PCR of selected Pax2 target genes show signiﬁcant down
regulation of Cited1, HNF4a, and Wnt4 upon deletion of PTIP. All qRT-PCRs were done in triplicate and normalized to Hprt expression levels with error bars representing one
standard deviation from the mean.
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Fig. 4. Whole mount in situ hybridization of select Pax2 target genes in kidney organ cultures with or without PTIP. Represenative kidneys are shown hybridized with the
indicated probes; wild-type (Cre-) rudiments are on the left and PTIP deleted rudiments (Creþ) are on the right. Genes that are minimally affected by the loss of PTIP are
show in panel (A), whereas (B) shows three genes whose expression is lower upon PTIP deletion. (C) and (D) Morphometric analyses of whole mount staining, taking both
surface area and intensity into account. Genes unaffected by the loss of PTIP are in C, whereas genes suppressed by the loss of PTIP are in D.
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terminal tail recognizes the 50 end of the DNA sequence. Further-
more, interactions between the paired-domain and the DNA
recognition sequences can change the conformation of the Pax
protein and the target DNAs (Chalepakis et al., 1994; Epstein J.
et al., 1994). The carboxy-terminus of Pax2/5/8 can bind to the
adaptor protein PTIP/Paxip1 to recruit the Mll3 or Mll4 histone
methyltransferases to imprint the activating H3K4me1/2/3 epige-
netic marks (Patel et al., 2007; Daniel et al., 2010; Schwab et al.,
2011). Yet, associations with the co-repressor Grg4/Tle4 displace
PTIP and the Mll complex and subsequently recruit an arginine
methyltransferase and the Polycomb repressor 2 complex (Patel
et al., 2012). Thus, Pax2 targets could be subject to activation or
repression depending on the availability of co-factors. Such co-
factor interactions may also depend on the local DNA sequence
context. Our screens in Pax2Egfp/Egfp mutants identiﬁed both posi-
tive and negatively regulated genes.
Because of the prior evidence linking PITP to Pax2 and gene
activation, we investigated the expression of potential Pax2 targets
in PTIP null embryonic kidneys. Using an organ culture system to
delete a conditional PTIP allele, we show that a subset of genes
whose expression is reduced in Pax2 mutants are also affected in
PTIP mutants kidneys. However, many genes that are presumptive
early targets of Pax2, those already expressed at the time of kidney
explant in our organ cultures, do not appear to require PTIP for
maintaining expression. These include Six2, Osr1 and Bmp7. This
underscores the epigenetic effects of Pax2 within the intermediate
mesoderm, as genes already expressed remain on, whereas certain
genes that are activated after explant and after PTIP deletion are
affected. However, Cited1, a marker of early cap mesenchyme is
affected in PTIP deletions, despite being expressed early in kidney
cultures, before deletion of PTIP. Whether similar results will be
observed with temporal Pax2 deletions awaits the analyses of a
conditional allele.
In summary, we have deﬁned a genetic network dependent on
Pax2 and, at least in part, dependent on PTIP. Such a network helps
deﬁne the intermediate mesoderm and the renal epithelial line-
age. In the absence of Pax2, the IM cells assume a pattern of gene
expression more consistent with paraxial mesoderm and its
derivatives. The data suggest that epigenetic mechanisms underlie
early lineage decisions and compartmentalization of the meso-
derm after gastrulation.
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